COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs

Ann Rheum Dis. 2022 Oct;81(10):e190. doi: 10.1136/annrheumdis-2020-218737. Epub 2020 Aug 5.
No abstract available

Keywords: autoimmune diseases; health care; immune system diseases; outcome assessment.

Publication types

  • Letter
  • Comment

MeSH terms

  • Autoimmune Diseases* / complications
  • Autoimmune Diseases* / drug therapy
  • COVID-19*
  • Humans
  • Immunomodulating Agents
  • Sjogren's Syndrome*

Substances

  • Immunomodulating Agents